The role of tyrosine kinase activity in endocytosis, compartmentation, and down-regulation of the epidermal growth factor receptor - PubMed (original) (raw)
. 1991 Jun 15;266(17):11083-94.
Affiliations
- PMID: 1645724
Free article
The role of tyrosine kinase activity in endocytosis, compartmentation, and down-regulation of the epidermal growth factor receptor
H S Wiley et al. J Biol Chem. 1991.
Free article
Abstract
Occupancy-induced down-regulation of cell surface epidermal growth factor (EGF) receptors attenuates signal transduction. To define mechanisms through which down-regulation of this class of growth factor receptors occurs, we have investigated the relative roles of ligand-induced internalization and recycling in this process. Occupied, kinase-active EGF receptors were internalized through a high affinity, saturable endocytic system at rates up to 10-fold faster than empty receptors. In contrast, full length EGF receptors lacking tyrosine kinase activity underwent internalization at a rate independent of occupancy. This "kinase-independent" internalization rate appeared to reflect constitutive receptor internalization since it was similar to the internalization rate of both receptors lacking a cytoplasmic domain and of antibodies bound to empty receptors. EGF internalized by either kinase-active or kinase-inactive receptors was efficiently recycled and was found within endosomes containing recycling transferrin receptors. However, targeting of internalized receptors to lysosomes did not require receptor kinase activity. All receptors that displayed ligand-induced internalization also underwent down-regulation, indicating that the proximal cause of down-regulation is occupancy-induced endocytosis. Tyrosine kinase activity greatly enhances this process by stabilizing receptor association with the endocytic apparatus.
Similar articles
- Ligand-induced internalization of the epidermal growth factor receptor is mediated by multiple endocytic codes analogous to the tyrosine motif found in constitutively internalized receptors.
Chang CP, Lazar CS, Walsh BJ, Komuro M, Collawn JF, Kuhn LA, Tainer JA, Trowbridge IS, Farquhar MG, Rosenfeld MG, et al. Chang CP, et al. J Biol Chem. 1993 Sep 15;268(26):19312-20. J Biol Chem. 1993. PMID: 8396132 - Quantitative analysis of the endocytic system involved in hormone-induced receptor internalization.
Lund KA, Opresko LK, Starbuck C, Walsh BJ, Wiley HS. Lund KA, et al. J Biol Chem. 1990 Sep 15;265(26):15713-23. J Biol Chem. 1990. PMID: 1975591 - Phosphorylation of the epidermal growth factor receptor at threonine 654 inhibits ligand-induced internalization and down-regulation.
Lund KA, Lazar CS, Chen WS, Walsh BJ, Welsh JB, Herbst JJ, Walton GM, Rosenfeld MG, Gill GN, Wiley HS. Lund KA, et al. J Biol Chem. 1990 Nov 25;265(33):20517-23. J Biol Chem. 1990. PMID: 2173710 - Endocytosis and intracellular sorting of receptor tyrosine kinases.
Alexander A. Alexander A. Front Biosci. 1998 Jul 26;3:d729-38. doi: 10.2741/A316. Front Biosci. 1998. PMID: 9671598 Review.
Cited by
- A guide to ERK dynamics, part 1: mechanisms and models.
Ram A, Murphy D, DeCuzzi N, Patankar M, Hu J, Pargett M, Albeck JG. Ram A, et al. Biochem J. 2023 Dec 13;480(23):1887-1907. doi: 10.1042/BCJ20230276. Biochem J. 2023. PMID: 38038974 Free PMC article. - EGFR trafficking: effect of dimerization, dynamics, and mutation.
Schultz DF, Billadeau DD, Jois SD. Schultz DF, et al. Front Oncol. 2023 Sep 11;13:1258371. doi: 10.3389/fonc.2023.1258371. eCollection 2023. Front Oncol. 2023. PMID: 37752992 Free PMC article. Review. - Preliminary Discovery of Small Molecule Inhibitors of Epidermal Growth Factor Receptor (EGFR) That Bind to the Extracellular Domain.
Di Liddo R, Verona M, Vaccarin C, Acquasaliente L, Schrenk S, Piccione M, Cenzi C, De Franco M, Dal Prà M, Ribaudo G, Ferlin MG, Conconi MT, Chilin A, Gandin V, Marzaro G. Di Liddo R, et al. Cancers (Basel). 2022 Jul 27;14(15):3647. doi: 10.3390/cancers14153647. Cancers (Basel). 2022. PMID: 35954311 Free PMC article. - Integration of liquid biopsy and pharmacogenomics for precision therapy of EGFR mutant and resistant lung cancers.
Kolesar J, Peh S, Thomas L, Baburaj G, Mukherjee N, Kantamneni R, Lewis S, Pai A, Udupa KS, Kumar An N, Rangnekar VM, Rao M. Kolesar J, et al. Mol Cancer. 2022 Feb 24;21(1):61. doi: 10.1186/s12943-022-01534-8. Mol Cancer. 2022. PMID: 35209919 Free PMC article. Review. - Substratum stiffness regulates Erk signaling dynamics through receptor-level control.
Farahani PE, Lemke SB, Dine E, Uribe G, Toettcher JE, Nelson CM. Farahani PE, et al. Cell Rep. 2021 Dec 28;37(13):110181. doi: 10.1016/j.celrep.2021.110181. Cell Rep. 2021. PMID: 34965432 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials